Star Health and Allied Insurance Company Limited is India's leading standalone health insurance provider offering retail, family, senior citizen, and corporate health insurance products. The company benefits from a broad distribution network including agents, banks, and digital channels. Rising healthcare costs continue to increase demand for medical insurance coverage. Product innovation and efficient claims management strengthen customer trust. Insurance penetration remains a major long-term growth opportunity.
| Market cap | Sales (TTM) | Net profit (TTM) | P/E | EPS (TTM) | P/B | ROE | Beta |
|---|---|---|---|---|---|---|---|
| ₹31,904 cr | — | — | 35.7 | 15.33 | 3.15 | 8.9% | 0.41 |
| Quarter | Sales ₹ cr | Net profit ₹ cr | EPS | EPS YoY | Sales YoY | Net margin |
|---|---|---|---|---|---|---|
| Mar 2026 | 5,599 | 111 | 1.89 | +18800.0% | +16.2% | 2.0% |
| Dec 2025 | 4,361 | 128 | 2.18 | -40.4% | +22.5% | 2.9% |
| Sep 2025 | 4,233 | 55 | 0.93 | -51.0% | +6.5% | 1.3% |
| Jun 2025 | 3,457 | 262 | 4.47 | -18.0% | +9.1% | 7.6% |
| Mar 2025 | 4,820 | 0 | 0.01 | -99.6% | +5.5% | 0.0% |
| Dec 2024 | 3,560 | 215 | 3.66 | — | — | 6.0% |
| Sep 2024 | 3,975 | 111 | 1.90 | — | — | 2.8% |
| Jun 2024 | 3,170 | 319 | 5.45 | — | — | 10.1% |
| Check | Result |
|---|---|
| Latest quarter EPS up 25%+ on a year ago | ✓ Pass |
| EPS growth accelerating over 3 quarters | ✓ Pass |
| Sales up 25%+, or sales growth accelerating | ✗ Fail |
| Annual EPS up 25%+ in each of the last 2 years | — Not assessable |
| Net margin above the same quarter last year | ✓ Pass |
| Method | Checks | Score | Verdict |
|---|---|---|---|
| Minervini | ✓ Close above the 150- and 200-day averages ✓ 150-day above 200-day ✓ 200-day rising for a month ✓ 50-day above the 150- and 200-day ✗ Close above the 50-day ✓ At least 25% above the 52-week low · low 425.15 ✓ Within 25% of the 52-week high · high 610.40 ✗ RS percentile 70 or more · RS 64 Trend template - the gate, measured: a modest 21-day edge. | 6/8 | 6 of 8 |
| Weinstein | Stan Weinstein's stage analysis on the 30-week moving average. | Stage 2 - advancing | |
| CAN SLIM | ✓ C latest quarter EPS up 25%+ — A annual EPS up 25%+ in each of the last 2 years · O'Neil asks 3; ~2 held ✓ N within 15% of the 52-week high · high 610.40 ✓ S more volume on up days than down days (50 sessions) · 2.03x ✗ L RS percentile 80 or more · RS 64 — I institutional sponsorship rising · shareholding not collected yet ✓ M market in an uptrend (40%+ of stocks above their 200-day) · breadth 45% William O'Neil's growth-leader checklist. | 4/5 | Strong |
| Darvas | ✓ Box top confirmed (3 sessions below the new high) · top 624.90 ✓ Box bottom confirmed (3 sessions holding) · bottom 513.00 ✗ Close above the box top · close 542.05 ✗ Volume at least 1.5x its 50-day average · 0.1x Nicolas Darvas's box: buy the breakout above a confirmed box after a new high. | 50/100 | In box |
| Turtle | ✗ Close above the prior 55-session high · 624.90 ✗ Close above the prior 20-session high · 572.55 ✗ Close below the prior 20-session low · 513.00 Donchian channel breakout - the Turtle traders' entry. | No signal | |
| Graham | ✗ Price at or below the Graham number · Graham number 243.63 ✗ P/E 15 or less · P/E 35.4 ✗ P/B 1.5 or less (or P/E x P/B 22.5 or less) · P/B 3.15 — Current ratio 2 or more — 10 years of positive earnings, 20 of dividends · history not held Benjamin Graham's defensive-investor tests. | 45/100 | Expensive |
| Stock | 1M % | 3M % | 6M % | 1Y % | 3Y % | 5Y % | P/E | P/B | ROE % | ROCE % | ROA % | D/E | EV/EBITDA | ₹ Cr | Sales TTM ₹ Cr | Profit TTM ₹ Cr | EPS | Beta |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| STARHEALTH this stock | -0.9 | -6.7 | +7.0 | +7.6 | -8.9 | — | 35.7 | 3.15 | 8.9 | — | — | — | — | 31,904 | — | — | 15.3 | 0.41 |
| SAKAR | -21.8 | +2.7 | +51.5 | +162.7 | +158.4 | +464.3 | 57.0 | 6.33 | 10.0 | 12.9 | — | 0.17 | 30.8 | 2,054 | 272 | 36 | 16.2 | 0.69 |
| KOVAI | -5.6 | -0.9 | +7.0 | +128.0 | +118.8 | +256.0 | 25.5 | 4.87 | 19.4 | — | — | — | — | 6,429 | — | — | 234.2 | — |
| AHCL | +17.8 | +79.8 | +86.2 | +112.4 | — | — | 11.1 | 6.23 | 47.4 | — | — | 0.19 | 30.7 | 1,434 | — | — | 2.4 | 0.44 |
| VIJAYA | -12.2 | +2.5 | +33.7 | +37.9 | +134.0 | +143.8 | 75.1 | 14.71 | 19.7 | 30.3 | — | 0.00 | 39.6 | 14,078 | 857 | 188 | 18.2 | 0.54 |
| ENTERO | -13.2 | +26.4 | +18.2 | +35.9 | — | — | 52.2 | 3.88 | 6.7 | 10.7 | — | 0.34 | 26.4 | 6,545 | 7,128 | 168 | 28.8 | 0.36 |
| AMANTA | -13.3 | -0.0 | +21.9 | +34.8 | — | — | 39.6 | 2.57 | — | — | — | 1.06 | — | — | 291 | 15 | 4.2 | 0.73 |
| YATHARTH | -14.8 | +14.4 | +30.6 | +19.8 | +147.7 | — | 51.6 | 5.18 | 10.0 | 12.4 | — | 0.14 | 30.2 | 9,356 | 1,334 | 174 | 18.8 | 0.88 |
| LALPATHLAB | -2.8 | +8.9 | +30.0 | +18.6 | +47.0 | -0.3 | 56.8 | 12.32 | 21.6 | 29.1 | — | 0.00 | 36.2 | 30,900 | 2,891 | 546 | 32.5 | 0.41 |
| THYROCARE | -15.3 | -15.2 | +19.9 | +13.6 | +151.4 | +22.7 | 42.6 | 12.80 | 28.8 | 37.8 | — | 0.00 | 28.2 | 7,497 | 876 | 176 | 11.1 | 0.47 |
| METROPOLIS | -13.1 | -9.5 | +9.2 | +7.1 | +37.5 | -24.5 | 53.4 | 7.11 | 13.4 | 19.6 | — | 0.01 | 26.3 | 10,763 | 1,710 | 203 | 9.7 | 0.43 |